Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ISHITA DRUGS vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ISHITA DRUGS ZYDUS LIFESCIENCES ISHITA DRUGS/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 20.5 20.0 102.4% View Chart
P/BV x 1.9 2.4 81.5% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ISHITA DRUGS   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ISHITA DRUGS
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ISHITA DRUGS/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs54674 8.1%   
Low Rs27331 8.2%   
Sales per share (Unadj.) Rs47.1149.1 31.6%  
Earnings per share (Unadj.) Rs2.722.7 11.8%  
Cash flow per share (Unadj.) Rs3.129.7 10.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs28.7166.1 17.3%  
Shares outstanding (eoy) m2.991,023.74 0.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.4 25.7%   
Avg P/E ratio x15.222.1 68.6%  
P/CF ratio (eoy) x13.116.9 77.1%  
Price / Book Value ratio x1.43.0 46.9%  
Dividend payout %011.0 0.0%   
Avg Mkt Cap Rs m122514,277 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m821,777 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m141152,652 0.1%  
Other income Rs m12,354 0.0%   
Total revenues Rs m142155,006 0.1%   
Gross profit Rs m1134,427 0.0%  
Depreciation Rs m17,130 0.0%   
Interest Rs m01,270 0.0%   
Profit before tax Rs m1028,381 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m25,117 0.0%   
Profit after tax Rs m823,264 0.0%  
Gross profit margin %7.722.6 34.3%  
Effective tax rate %22.818.0 126.6%   
Net profit margin %5.715.2 37.5%  
BALANCE SHEET DATA
Current assets Rs m100122,614 0.1%   
Current liabilities Rs m2678,394 0.0%   
Net working cap to sales %52.629.0 181.7%  
Current ratio x3.81.6 244.3%  
Inventory Days Days10793 115.0%  
Debtors Days Days14,039,19880 17,577,878.4%  
Net fixed assets Rs m12144,382 0.0%   
Share capital Rs m301,024 2.9%   
"Free" reserves Rs m56168,972 0.0%   
Net worth Rs m86169,996 0.1%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m113266,996 0.0%  
Interest coverage x42.723.3 183.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.6 219.0%   
Return on assets %7.49.2 80.2%  
Return on equity %9.413.7 68.4%  
Return on capital %12.417.1 72.7%  
Exports to sales %00-   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA21,869 0.0%   
Fx inflow Rs m063,065 0.0%   
Fx outflow Rs m021,869 0.0%   
Net fx Rs m041,196 0.0%   
CASH FLOW
From Operations Rs m3121,041 0.1%  
From Investments Rs m-911,544 -0.1%  
From Financial Activity Rs mNA-8,683 -0.0%  
Net Cashflow Rs m2123,729 0.1%  

Share Holding

Indian Promoters % 49.3 75.0 65.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.5 -  
FIIs % 0.0 2.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.7 25.0 202.6%  
Shareholders   4,944 408,231 1.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ISHITA DRUGS With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    PIRAMAL ENTERPRISES    


More on ISHITA DRUGS vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ISHITA DRUGS vs Cadila Healthcare Share Price Performance

Period ISHITA DRUGS Cadila Healthcare S&P BSE HEALTHCARE
1-Day -1.33% -0.46% 0.14%
1-Month -11.43% -6.88% 0.27%
1-Year 36.10% -12.32% -6.96%
3-Year CAGR 67.47% 15.61% 20.12%
5-Year CAGR 20.57% -1.95% 11.05%

* Compound Annual Growth Rate

Here are more details on the ISHITA DRUGS share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ISHITA DRUGS hold a 49.3% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ISHITA DRUGS and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ISHITA DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ISHITA DRUGS, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 100 Points | Reliance, Asian Paints Top Gainers | Metal Stocks Bleed while Auto Stocks Rise(10:30 am)

Asian share markets are lower today as rare protests in major Chinese cities against the country's strict zero-Covid policy raised worries about management of the virus in the world's second-largest economy.